Gu J, He Y, He C, Zhang Q, Huang Q, Bai S
Signal Transduct Target Ther. 2025; 10(1):84.
PMID: 40069202
PMC: 11897415.
DOI: 10.1038/s41392-025-02166-2.
Smadja D, Abreu M
Front Neurosci. 2025; 19:1475376.
PMID: 39967803
PMC: 11832498.
DOI: 10.3389/fnins.2025.1475376.
Wang Y, Fernandez A, Pei X, Liu B, Shen L, Yan Y
Nucleic Acids Res. 2024; 52(21):13057-13072.
PMID: 39470734
PMC: 11602123.
DOI: 10.1093/nar/gkae938.
Zayed M, Kim Y, Jeong B
Front Cell Dev Biol. 2024; 12:1411529.
PMID: 39105172
PMC: 11298377.
DOI: 10.3389/fcell.2024.1411529.
Geng Y, Gai Y, Zhang Y, Zhao S, Jiang A, Li X
Int J Mol Sci. 2024; 25(14).
PMID: 39063205
PMC: 11277129.
DOI: 10.3390/ijms25147963.
Small molecule inhibitor targeting the Hsp70-Bim protein-protein interaction in estrogen receptor-positive breast cancer overcomes tamoxifen resistance.
Song T, Zhang H, Zhao Q, Hu Z, Wang Z, Song Y
Breast Cancer Res. 2024; 26(1):33.
PMID: 38409088
PMC: 10895875.
DOI: 10.1186/s13058-024-01790-0.
Externally Applied Electromagnetic Fields and Hyperthermia Irreversibly Damage Cancer Cells.
Obrador E, Jihad-Jebbar A, Salvador-Palmer R, Lopez-Blanch R, Oriol-Caballo M, Moreno-Murciano M
Cancers (Basel). 2023; 15(13).
PMID: 37444524
PMC: 10340829.
DOI: 10.3390/cancers15133413.
HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances.
Zhao K, Zhou G, Liu Y, Zhang J, Chen Y, Liu L
Biomolecules. 2023; 13(4).
PMID: 37189349
PMC: 10136146.
DOI: 10.3390/biom13040601.
Heat shock proteins and cancer: The FoxM1 connection.
Alimardan Z, Abbasi M, Hasanzadeh F, Aghaei M, Khodarahmi G, Kashfi K
Biochem Pharmacol. 2023; 211:115505.
PMID: 36931349
PMC: 10134075.
DOI: 10.1016/j.bcp.2023.115505.
Avenanthramide Improves Colonic Damage Induced by Food Allergies in Mice through Altering Gut Microbiota and Regulating Hsp70-NF-κB Signaling.
Liu P, Zhang M, Liu T, Mo R, Wang H, Zhang G
Nutrients. 2023; 15(4).
PMID: 36839351
PMC: 9962348.
DOI: 10.3390/nu15040992.
Synthetic Small Molecule Modulators of Hsp70 and Hsp40 Chaperones as Promising Anticancer Agents.
Nitzsche B, Hopfner M, Biersack B
Int J Mol Sci. 2023; 24(4).
PMID: 36835501
PMC: 9964478.
DOI: 10.3390/ijms24044083.
Effects of Avenanthramide on the Small Intestinal Damage through Hsp70-NF-κB Signaling in an Ovalbumin-Induced Food Allergy Model.
Liu P, Liu T, Zhang M, Mo R, Zhou W, Li D
Int J Mol Sci. 2022; 23(23).
PMID: 36499554
PMC: 9739943.
DOI: 10.3390/ijms232315229.
Involvement of heat shock proteins and parkin/α-synuclein axis in Parkinson's disease.
Aghazadeh N, Beilankouhi E, Fakhri F, Gargari M, Bahari P, Moghadami A
Mol Biol Rep. 2022; 49(11):11061-11070.
PMID: 36097120
DOI: 10.1007/s11033-022-07900-5.
Advances in the study of HSP70 inhibitors to enhance the sensitivity of tumor cells to radiotherapy.
Du S, Liu Y, Yuan Y, Wang Y, Chen Y, Wang S
Front Cell Dev Biol. 2022; 10:942828.
PMID: 36036010
PMC: 9399644.
DOI: 10.3389/fcell.2022.942828.
Heat Shock Proteins 70 Regulate Cell Motility and Invadopodia-Associated Proteins Expression in Oral Squamous Cell Carcinoma.
Ding L, Zhang J, Yang S, Wu J, Su T, Wang W
Front Endocrinol (Lausanne). 2022; 13:890218.
PMID: 35957827
PMC: 9362981.
DOI: 10.3389/fendo.2022.890218.
Abrogating the Interaction Between p53 and Mortalin (Grp75/HSPA9/mtHsp70) for Cancer Therapy: The Story so far.
Elwakeel A
Front Cell Dev Biol. 2022; 10:879632.
PMID: 35493098
PMC: 9047732.
DOI: 10.3389/fcell.2022.879632.
Proteostasis Regulators in Cystic Fibrosis: Current Development and Future Perspectives.
Brusa I, Sondo E, Falchi F, Pedemonte N, Roberti M, Cavalli A
J Med Chem. 2022; 65(7):5212-5243.
PMID: 35377645
PMC: 9014417.
DOI: 10.1021/acs.jmedchem.1c01897.
Transient 40 °C-shock potentiates cytotoxic responses of Vδ2 γδ T cell via HSP70 upregulation.
Lin L, Chen Y, Chen D, Shu J, Hu Y, Yin Z
Cancer Immunol Immunother. 2022; 71(10):2391-2404.
PMID: 35195762
PMC: 10992275.
DOI: 10.1007/s00262-022-03164-x.
Targeting HSPA1A in ARID2-deficient lung adenocarcinoma.
Wang X, Wang Y, Fang Z, Wang H, Zhang J, Zhang L
Natl Sci Rev. 2021; 8(10):nwab014.
PMID: 34858604
PMC: 8566174.
DOI: 10.1093/nsr/nwab014.
Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis.
Theivanthiran B, Haykal T, Cao L, Holtzhausen A, Plebanek M, DeVito N
Cancers (Basel). 2021; 13(19).
PMID: 34638239
PMC: 8507548.
DOI: 10.3390/cancers13194753.